The experience of using dexmedetomidine as an adjuvant of anesthesia in ophthalmic surgery

Various techniques are applied to reduce the severity of postoperative pain and discomfort in patients. The purpose this research work was evaluate effectiveness safety Dexmedetomidine as an adjuvant anesthesia ophthalmic surgery. study included 80 patients who underwent corneal transplantation on basis Dnepropetrovsk Regional Clinical Ophthalmologic Hospital. Patients were divided into 2 groups: control (group K) – 30 men main D) 50 ones. Multicomponent balanced both groups. Sibazone administered sedative medicine group K, Dexmedetomedin D. criteria for evaluating results hallmarked: hemodynamic stability during surgery, amount opiates, intraoperative syndrome by ANI index (ANI analgesia nociception index), frequency nausea vomiting (PONV). Both schemes allowed avoiding pronounced fluctuations parameters gas exchange at all stages study. Analyzing pain, we found that K relief could be considered insufficient first 7 minutes most traumatic stage while D did not fall below 50. Statistically significant differences obtained minute 1, 2, 5, 6, number episodes surgery statistically significantly higher than quality period it determined, level Visual Analog Scale (VAS) after awakening groups equal 0. At next three (2 hours, 6 hours morning), In addition, determined need narcotic analgesics These given data allow us conclude is effective transplantation.